Paper

Bimekizumab efficacy in male and female patients with axial spondyloarthritis: 52-week results from the phase 3 BE MOBILE trials

Rheumatology · 2026 · Martin Rudwaleit, Sofia Ramiro, Denis Poddubnyy et al.